Galectin Therapeutics Inc (GALT)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -105.917 | -175.055 | -228.556 | -70.221 | -60.466 | -85.956 | -123.187 | -181.085 |
Return on Equity (%) | -157.772 | -357.857 | -647.879 | -82.284 | -71.153 | -262.792 | 235.423 | 93.46 |
Return on Invested Capital (%) | -151.588 | -291.591 | -359.129 | -51.541 | -67.439 | -108.24 | -195.22 | -407.253 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.234 | 0.026 | 0.12 | 0.571 | 0.303 | 0.032 | -0.391 | -0.717 |
Earnings Per Share | -0.509 | -0.374 | -0.261 | -0.253 | -0.295 | -0.373 | -0.472 | -0.529 |
Cash Per Share | 0.35 | 0.065 | 0.143 | 0.595 | 0.339 | 0.482 | 0.226 | 0.303 |
Working Capital Per Share | 0.274 | 0.018 | 0.117 | 0.569 | 0.301 | 0.399 | 0.092 | 0.142 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.488 | -0.347 | -0.241 | -0.167 | -0.293 | -0.371 | -0.471 | -0.485 |
EBITDA Per Share | -0.488 | -0.347 | -0.241 | -0.167 | -0.293 | -0.371 | -0.471 | -0.485 |
Free Cash Flow Per Share | -0.509 | -0.374 | -0.261 | -0.253 | -0.296 | -0.374 | -0.472 | -0.529 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 32,91M | 35,79M | 41,19M | 56,9M | 57,08M | 59,34M | 59,43M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 59,43M | N/A | 59,58M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 78,45M |
Ratio cours/bénéfice | -1,74 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 3,03 |
Ratio prix/valeur comptable | -1,29 |
Rendement de dividende | - |
Actions en circulation | 62,76M |
Volume moyen (1 semaine) | 301,5k |
Volume moyen (1 mois) | 1,54M |
Variation sur 52 semaines | -31,11% |
Plus haut sur 52 semaines | 4,2684 |
Plus bas sur 52 semaines | 0,726041 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales